Vanguard Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,112
| Closed | -$74.9K | – | 4450 |
|
|
2023
Q4 | $74.9K | Buy |
+13,112
| New | +$74.9K | ﹤0.01% | 4337 |
|
|
2023
Q2 | – | Sell |
-989,154
| Closed | -$7.46M | – | 4549 |
|
|
2023
Q1 | $7.46M | Buy |
989,154
+12,597
| +1% | +$95K | ﹤0.01% | 3105 |
|
|
2022
Q4 | $9.89M | Buy |
976,557
+97,665
| +11% | +$989K | ﹤0.01% | 2950 |
|
|
2022
Q3 | $8.69M | Sell |
878,892
-15,282
| -2% | -$151K | ﹤0.01% | 3017 |
|
|
2022
Q2 | $9.52M | Buy |
+894,174
| New | +$9.52M | ﹤0.01% | 3014 |
|